Other Healthcare Technology Systems · New York, NY · Founded 2013 · Privately Held (backing)
Developer of a bone reconstruction technology designed for skeletal reconstruction through three-dimensional design and living cells. EpiBone is based in New York, NY and was founded in 2013. Its last reported valuation was $44.3 million in Jan 2020. It has raised $71.1 million across 4 recorded rounds; the latest was a $4.3 million seed round in Sep 2025.
Last reported valuation
$44.3M
Oct 2026
Priced at
—
Total raised
$71.1M
Last round
Seed Round
Sep 2025
No prints on record
No secondary trades in EpiBone shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of EpiBone with a free account
·The complete investor list: 50 names
·Watch EpiBone: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of EpiBone stock.
